Amrutkar M, Guttorm SJT, Finstadsveen AV, Labori KJ, Eide L, Rootwelt H, Elgstøen KBP, Gladhaug IP, Verbeke CS(2024) Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13759, PubMed 39545923
Janssen BV, Oteman B, Ali M, Valkema PA, Adsay V, Basturk O, Chatterjee D, Chou A, Crobach S, Doukas M, Drillenburg P, Esposito I, Gill AJ, Hong SM, Jansen C, Kliffen M, Mittal A, Samra J, van Velthuysen MF, Yavas A, Kazemier G, Verheij J, Steyerberg E, Besselink MG, Wang Het al.(2024) Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2): International Improvement and Validation Study Am J Surg Pathol, 48(9), 1108-1116 DOI 10.1097/PAS.0000000000002270, PubMed 38985503
Farnes I, Lund-Iversen M, Aabakken L, Verbeke C, Labori KJ(2024) Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study Scand J Gastroenterol, 59(9), 1093-1096 DOI 10.1080/00365521.2024.2373115, PubMed 38957079